REFERENCES
1. Oliai C, Douek ML, Rhoane C, et al. Clinical features of pseudocirrhosis in metastatic breast cancer. Breast Cancer Res Treat. 2019;177:409-17.
3. Young ST, Paulson EK, Washington K, Gulliver DJ, Vredenburgh JJ, Baker ME. CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis. AJR Am J Roentgenol. 1994;163:1385-8.
4. Engelman D, Moreau M, Lepida A, Zaouak Y, Paesmans M, Awada A. Metastatic breast cancer and pseudocirrhosis: an unknown clinical entity. ESMO Open. 2020;5:e000695.
5. Manenti A, Caramaschi S, Manco G, Bonetti LR. Neoplastic pseudocirrhosis pathophysiological deepening. Dig Dis Sci. 2024;69:4493-4.
6. Kang SP, Taddei T, McLennan B, Lacy J. Pseudocirrhosis in a pancreatic cancer patient with liver metastases: a case report of complete resolution of pseudocirrhosis with an early recognition and management. World J Gastroenterol. 2008;14:1622-4.
7. Harry BL, Smith ML, Burton JR Jr, Dasari A, Eckhardt SG, Diamond JR. Medullary thyroid cancer and pseudocirrhosis: case report and literature review. Curr Oncol. 2012;19:e36-41.
8. Gounder J, Frankel A, Ngai S. Isolated serosal liver infiltration mimicking cirrhosis in gastroesophageal junction adenocarcinoma: a report of 2 cases. Radiol Case Rep. 2026;21:436-9.
9. Lee SL, Chang ED, Na SJ, et al. Pseudocirrhosis of breast cancer metastases to the liver treated by chemotherapy. Cancer Res Treat. 2014;46:98-103.
10. Phillips E, Sethi M, Vasanthakumar S, et al. The clinical features and outcomes of pseudocirrhosis in breast cancer. Cancers. 2024;16:2822.
11. Adike A, Karlin N, Menias C, Carey EJ. Pseudocirrhosis: a case series and literature review. Case Rep Gastroenterol. 2016;10:381-91.
12. Jeong WK, Choi SY, Kim J. Pseudocirrhosis as a complication after chemotherapy for hepatic metastasis from breast cancer. Clin Mol Hepatol. 2013;19:190-4.
14. Qayyum A, Lee GK, Yeh BM, Allen JN, Venook AP, Coakley FV. Frequency of hepatic contour abnormalities and signs of portal hypertension at CT in patients receiving chemotherapy for breast cancer metastatic to the liver. Clin Imaging. 2007;31:6-10.
15. Jha P, Poder L, Wang ZJ, Westphalen AC, Yeh BM, Coakley FV. Radiologic mimics of cirrhosis. AJR Am J Roentgenol. 2010;194:993-9.
16. Gibert-Ramos A, Sanfeliu-Redondo D, Aristu-Zabalza P, et al. The hepatic sinusoid in chronic liver disease: the optimal milieu for cancer. Cancers. 2021;13:5719.
17. Yang M, Zhang C. The role of liver sinusoidal endothelial cells in cancer liver metastasis. Am J Cancer Res. 2021;11:1845-60.
18. Parikh P, Rose T, Jeong D, et al. Diffuse intrasinusoidal hepatic metastasis from breast cancer: Multimodality imaging with pathology correlation. Radiol Case Rep. 2021;16:1005-9.
19. Huppert LA, Walker Z, Li M, et al. Clinical characteristics and outcomes in patients with metastatic breast cancer and pseudocirrhosis: a single center retrospective cohort study. Breast Cancer Res Treat. 2023;197:137-48.
20. Sadlik G, Anderson RC, Lei X, Cen SY, Duddalwar VA, Fong TL. Pseudocirrhosis: a case series with clinical and radiographic correlation and review of the literature. Dig Dis Sci. 2024;69:1004-14.
21. Sass DA, Clark K, Grzybicki D, Rabinovitz M, Shaw-Stiffel TA. Diffuse desmoplastic metastatic breast cancer simulating cirrhosis with severe portal hypertension: a case of “pseudocirrhosis”. Dig Dis Sci. 2007;52:749-52.
22. Vuppalanchi R, Saxena R, Storniolo AMV, Chalasani N. Pseudocirrhosis and liver failure in patients with metastatic breast cancer after treatment with palbociclib. Hepatology. 2017;65:1762-4.
23. Zeina AR, Abu-Mouch S, Mari A. Pseudocirrhosis in metastatic breast cancer. Isr Med Assoc J. 2017;19:328.
24. Takata K, Mogi A, Yamauchi R, Shakado S, Hirai F. Pseudocirrhosis due to desmoplastic response to chemotherapy in breast cancer liver metastases. Cureus. 2022;14:e25321.
25. Allison KH, Fligner CL, Parks WT. Radiographically occult, diffuse intrasinusoidal hepatic metastases from primary breast carcinomas: a clinicopathologic study of 3 autopsy cases. Arch Pathol Lab Med. 2004;128:1418-23.
26. Reshamwala PA, Kleiner DE, Heller T. Nodular regenerative hyperplasia: not all nodules are created equal. Hepatology. 2006;44:7-14.
27. Gentilucci UV, Gallo P, Perrone G, et al. Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge. World J Gastroenterol. 2011;17:2580-4.
28. Valla DC, Cazals-Hatem D. Sinusoidal obstruction syndrome. Clin Res Hepatol Gastroenterol. 2016;40:378-85.
29. Nascimento AB, Mitchell DG, Rubin R, Weaver E. Diffuse desmoplastic breast carcinoma metastases to the liver simulating cirrhosis at MR imaging: report of two cases. Radiology. 2001;221:117-21.
30. Borja ER, Hori JM, Pugh RP. Metastatic carcinomatosis of the liver mimicking cirrhosis: case report and review of the literature. Cancer. 1975;35:445-9.
31. Mitchell ML, Filippone MD, Wozniak TF. Metastatic carcinomatous cirrhosis and hepatic hemosiderosis in a patient heterozygous for the H63D genotype. Arch Pathol Lab Med. 2001;125:1084-7.
32. Nakajima T, Sekoguchi S, Nishikawa T, et al. Multifocal intraportal invasion of breast carcinoma diagnosed by laparoscopy-assisted liver biopsy. World J Gastroenterol. 2005;11:2360-3.
33. Fournier C, Tisman G, Kleinman R, Park Y, Macdonald WD. Clinical evidence for overcoming capecitabine resistance in a woman with breast cancer terminating in radiologically occult micronodular pseudo-cirrhosis with portal hypertension: a case report. J Med Case Rep. 2010;4:112.
34. Graber I, Dumortier J, Poncet G, Queneau PE, Mathevet P, Scoazec JY. Hepar lobatum carcinomatosum revealing an occult metastatic lobular carcinoma of the breast. Ann Diagn Pathol. 2010;14:438-42.
35. Jüngst C, Krämer J, Schneider G, Lammert F, Zimmer V. Subacute liver failure by pseudocirrhotic metastatic breast cancer infiltration. Ann Hepatol. 2013;12:834-6.
36. Hidalgo-Blanco A, Aguirresarobe-Gil de San Vicente M, Aresti S, de Miguel E, Cabriada-Nuno JL. Pseudocirrhosis in metastatic breast cancer. Gastroenterol Hepatol. 2018;41:111-3.
37. Knouse P, Hancock C, Iwaz S, Kaiser P. Metastatic carcinomatosis cirrhosis: a rare pattern of metastasis. Cureus. 2019;11:e3876.
38. Millard T, Gupta A, Brenin C, Marshall P, Dillon P. Radiographically occult carcinomatous spread of breast cancer to the liver: a challenging case. Case Rep Oncol Med. 2019;2019:4935615.
39. Hoshina H, Takei H, Nakamura M, Nishimoto F, Hanamura S. Carcinomatous cirrhosis as radiographically occult liver metastases of breast cancer: a systematic literature review. Cancer Treat Res Commun. 2021;28:100388.
40. Aloysius MM, Zaitoun AM, Beckingham IJ, et al. The pathological response to neoadjuvant chemotherapy with FOLFOX-4 for colorectal liver metastases: a comparative study. Virchows Arch. 2007;451:943-8.
41. Aoyagi T, Takabe K, Tamanuki T, Matsubara H, Matsuzaki H. Pseudocirrhosis after chemotherapy in breast cancer, case reports. Breast Cancer. 2018;25:614-8.
42. Rubbia-Brandt L, Audard V, Sartoretti P, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol. 2004;15:460-6.
43. Carreras E. Veno-occlusive disease of the liver after hemopoietic cell transplantation. Eur J Haematol. 2000;64:281-91.
44. European Association for the Study of the Liver. Electronic address: [email protected], European Association for the Study of the Liver. EASL Clinical Practice Guidelines on vascular diseases of the liver. J Hepatol. 2026;84:399-456.
45. Zhang Y, Yan Y, Song B. Noninvasive imaging diagnosis of sinusoidal obstruction syndrome: a pictorial review. Insights Imaging. 2019;10:110.
47. Morris JM, Oien KA, McMahon M, et al. Nodular regenerative hyperplasia of the liver: survival and associated features in a UK case series. Eur J Gastroenterol Hepatol. 2010;22:1001-5.
48. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology. 1990;11:787-97.
49. Hartleb M, Gutkowski K, Milkiewicz P. Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension. World J Gastroenterol. 2011;17:1400-9.
50. Ames JT, Federle MP, Chopra K. Distinguishing clinical and imaging features of nodular regenerative hyperplasia and large regenerative nodules of the liver. Clin Radiol. 2009;64:1190-5.
51. Höpfner M, Scheel AH, Braun M, Rüschoff J, Löser C. Unusual nodular regenerative hyperplasia mimicking liver metastases in CEUS. Ultraschall Med. 2014;35:199-202.
52. Cervoni JP, Dobrin A, Sailley N, et al. [Hepar lobatum carcinomatusum: a rare cause of portal hypertension complicating hepatic metastases in breast cancer]. Gastroenterol Clin Biol. 2008;32:740-4.
53. Ibrahim AM, Bhandari B, Soriano PK, et al. Hepatic involvement in systemic sarcoidosis. Am J Case Rep. 2018;19:1212-5.
54. Ebert EC, Kierson M, Hagspiel KD. Gastrointestinal and hepatic manifestations of sarcoidosis. Am J Gastroenterol. 2008;103:3184-92.
55. Malhotra A, Naniwadekar A, Sood G. Hepatobiliary and pancreatic: cirrhosis secondary to hepatic sarcoidosis. J Gastroenterol Hepatol. 2008;23:1942.
56. Ungprasert P, Carmona EM, Crowson CS, Matteson EL. Diagnostic utility of angiotensin-converting enzyme in sarcoidosis: a population-based study. Lung. 2016;194:91-5.
57. Marsh RL, Kelly S, Mumtaz K, Kaffenberger J. Utility and limitations of transient elastography to monitor hepatic steatosis, hepatic fibrosis, and methotrexate-associated hepatic disease in psoriasis: a systematic review. J Clin Aesthet Dermatol. 2021;14:24-8.
58. Reynolds AR, Furlan A, Fetzer DT, et al. Infiltrative hepatocellular carcinoma: what radiologists need to know. Radiographics. 2015;35:371-86.
59. Kneuertz PJ, Demirjian A, Firoozmand A, et al. Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes. Ann Surg Oncol. 2012;19:2897-907.
60. Jang ES, Yoon JH, Chung JW, et al. Survival of infiltrative hepatocellular carcinoma patients with preserved hepatic function after treatment with transarterial chemoembolization. J Cancer Res Clin Oncol. 2013;139:635-43.
61. Park YS, Lee CH, Kim BH, et al. Using Gd-EOB-DTPA-enhanced 3-T MRI for the differentiation of infiltrative hepatocellular carcinoma and focal confluent fibrosis in liver cirrhosis. Magn Reson Imaging. 2013;31:1137-42.
62. Lim S, Kim YK, Park HJ, Lee WJ, Choi D, Park MJ. Infiltrative hepatocellular carcinoma on gadoxetic acid-enhanced and diffusion-weighted MRI at 3.0T. J Magn Reson Imaging. 2014;39:1238-45.
63. Rosenkrantz AB, Lee L, Matza BW, Kim S. Infiltrative hepatocellular carcinoma: comparison of MRI sequences for lesion conspicuity. Clin Radiol. 2012;67:e105-11.
64. Farinati F, Marino D, De Giorgio M, et al. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? Am J Gastroenterol. 2006;101:524-32.
65. Zhang J, Chen G, Zhang P, et al. The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. PLoS One. 2020;15:e0228857.
66. Peng SY, Chen WJ, Lai PL, Jeng YM, Sheu JC, Hsu HC. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations. Int J Cancer. 2004;112:44-50.
67. Mehta N, Fidelman N, Sarkar M, Yao FY. Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2013;11:572-8.
68. Demirjian A, Peng P, Geschwind JF, et al. Infiltrating hepatocellular carcinoma: seeing the tree through the forest. J Gastrointest Surg. 2011;15:2089-97.
69. Shreve LA, O'Leary C, Clark TWI, Stavropoulos SW, Soulen MC. Transjugular intrahepatic portosystemic shunt for the management of symptomatic malignant pseudocirrhosis. J Gastrointest Oncol. 2022;13:279-87.
70. Villani R, Di Cosimo F, Sangineto M, Romano AD, Serviddio G. Pseudocirrhosis and portal hypertension in patients with metastatic cancers: a systematic review and meta-analysis. Sci Rep. 2022;12:19865.
